Member Info for Nolupus

That would make sense ...

Any sources for that chatter ??

Breakout , pullback and boost ...as planned ....

Sold some at 48, as I was over invested in this share according to my initial investment plan .....

Simmo222,

I have always stated that I don't believe that Astra will be a partner for SNG001 for the simple reason that
1) they have their own product for COPD
2) they handed back the rights to SNG001 before

If you can please find a case where AStra handed back the rights to a product and came back to partner that product later ...

Please let me know ....

SImmo,
Please don't go down that road as credibility is not your forte ...

If you had mentioned Charnwood or Alderly Park instead of Macclesfield ... well whatever

As long as we close above 42.....

Looking good

John D. .....

Would have left Pascal know ...:-)

Anyway , when AStra leaves they don't come back :-)

SImmo,

You should know that all decisions in the respiratory area, are made in Sweden and with the VP in US :-)

Any other speculation is just that ....

Sharesting ,

Aspirations and convictions are great things but we can agree that for the time being all We can say is that there is potential :-)

I cannot understand why you have always mentionned Astra as being THE future partner for SYNAIRGEN ....

Not many followers here in EVG land ....

Wonder why ?

Seb ,

Science is science and I fully agree with Richard's stance .... Data is king ...
Talk is cheap , but results are results and therefore , anyone saying that SNG001 is better than this product or worse than this other product is only talking ...

Without results SNG001 , is a product with potential ........awaiting proof of efficacy !

Seb,

I presume you're implying that the Astra product is more advanced and better than SNG001 ??

More advanced in the regulatory process... Yes

A better product .... only time will tell, Data is King ...

Market cap =

1) pipeline milestones
2) finance and funding - cashburn
3) speculation and timing in regards to readouts and partnerships

As we have already stated ... Potential has to be transformed into milestones before we see the rerate in the market cap ...

We are in the TIme zone for results so let's hope for the best whilst being prepared for the worst. :-)

https://www.fiercebiotech.com/medtech/astrazeneca-spins-up-new-partnership-propeller-health-to-add-smart-features-to-its

Astra , have their own molecules for COPD

, https://www.astrazeneca.com/media-centre/press-releases/2019/astrazenecas-triple-combination-therapy-approved-in-china-for-patients-with-copd-23122019.html

https://www.astrazeneca.com/what-science-can-do/labtalk-blog/respiratory/transforming-the-future-of-care-for-copd-patients.html

But

https://endpts.com/hit-by-surprise-setback-astrazeneca-scrambles-to-explain-why-its-two-in-one-copd-inhaler-fails-to-beat-gsk-rival/

https://app.quotemedia.com/data/downloadFiling?type=HTML&webmasterId=501&ref=115075108&CK=1464165

Hi Jonah ,

Yes keeping an eye on interferon for early on patients but we have yet to find a very effective molecule against the cytokine Storm patients ...
Keep save in the meantime , IMM won't be paying you interest on your investment for quite a while , if ever :-)

Looks like we will try and test the 14 p next week if we move forward or

Back to approx 8p if not :-)

My bet is up but only time will tell

Not many people here ....

Do we have to wait for 20p ?

Should be a very interesting week ahead ..

Let's see what it brings :-)